AIM: To study the effects of probiotic metabolites on maturation stage of antigen-presenting immune cells. METHODS: Ganeden Bacillus coagulans 30 (GBC30) bacterial cultures in log phase were used to isolate the secreted metabolite (MET) fraction. A second fraction was made to generate a crude cell-wall-enriched fraction, by centrifugation and lysis, followed by washing. A preparation of MET was subjected to size exclusion centrifugation, generating three fractions: < 3 kDa, 3-30 kDa, and 30-200 kDa and activities were tested in comparison to crude MET and cell wall in primary cultures of human peripheral blood mononuclear cell (PBMC) as a source of antigen-presenting mononuclear phagocytes. The maturation status of mononuclear phagocytes was evaluated by staining with monoclonal antibodies towards CD14, CD16, CD80 and CD86 and analyzed by flow cytometry. RESULTS: Treatment of PBMC with MET supported maturation of mononuclear phagocytes toward both macrophage and dendritic cell phenotypes. The biological activity unique to the metabolites included a reduction of CD14+ CD16+ pro-inflammatory cells, and this property was associated with the high molecular weight metabolite fraction. Changes were also seen for the dendritic cell maturation markers CD80 and CD86. On CD14(dim) cells, an increase in both CD80 and CD86 expression was seen, in contrast to a selective increase in CD86 expression on CD14(bright) cells. The co-expression of CD80 and CD86 indicates effective antigen presentation to T cells and support of T helper cell differentiation. The selective expression of CD86 in the absence of CD80 points to a role in generating T regulatory cells. CONCLUSION: The data show that a primary mechanism of action of GBC30 metabolites involves support of more mature phenotypes of antigen-presenting cells, important for immunological decision-making.
AIM: To study the effects of probiotic metabolites on maturation stage of antigen-presenting immune cells. METHODS: Ganeden Bacillus coagulans 30 (GBC30) bacterial cultures in log phase were used to isolate the secreted metabolite (MET) fraction. A second fraction was made to generate a crude cell-wall-enriched fraction, by centrifugation and lysis, followed by washing. A preparation of MET was subjected to size exclusion centrifugation, generating three fractions: < 3 kDa, 3-30 kDa, and 30-200 kDa and activities were tested in comparison to crude MET and cell wall in primary cultures of human peripheral blood mononuclear cell (PBMC) as a source of antigen-presenting mononuclear phagocytes. The maturation status of mononuclear phagocytes was evaluated by staining with monoclonal antibodies towards CD14, CD16, CD80 and CD86 and analyzed by flow cytometry. RESULTS: Treatment of PBMC with MET supported maturation of mononuclear phagocytes toward both macrophage and dendritic cell phenotypes. The biological activity unique to the metabolites included a reduction of CD14+ CD16+ pro-inflammatory cells, and this property was associated with the high molecular weight metabolite fraction. Changes were also seen for the dendritic cell maturation markers CD80 and CD86. On CD14(dim) cells, an increase in both CD80 and CD86 expression was seen, in contrast to a selective increase in CD86 expression on CD14(bright) cells. The co-expression of CD80 and CD86 indicates effective antigen presentation to T cells and support of T helper cell differentiation. The selective expression of CD86 in the absence of CD80 points to a role in generating T regulatory cells. CONCLUSION: The data show that a primary mechanism of action of GBC30 metabolites involves support of more mature phenotypes of antigen-presenting cells, important for immunological decision-making.
Authors: J Ochoa-Repáraz; D W Mielcarz; Y Wang; S Begum-Haque; S Dasgupta; D L Kasper; L H Kasper Journal: Mucosal Immunol Date: 2010-06-09 Impact factor: 7.313
Authors: Karen E Nelson; George M Weinstock; Sarah K Highlander; Kim C Worley; Heather Huot Creasy; Jennifer Russo Wortman; Douglas B Rusch; Makedonka Mitreva; Erica Sodergren; Asif T Chinwalla; Michael Feldgarden; Dirk Gevers; Brian J Haas; Ramana Madupu; Doyle V Ward; Bruce W Birren; Richard A Gibbs; Barbara Methe; Joseph F Petrosino; Robert L Strausberg; Granger G Sutton; Owen R White; Richard K Wilson; Scott Durkin; Michelle Gwinn Giglio; Sharvari Gujja; Clint Howarth; Chinnappa D Kodira; Nikos Kyrpides; Teena Mehta; Donna M Muzny; Matthew Pearson; Kymberlie Pepin; Amrita Pati; Xiang Qin; Chandri Yandava; Qiandong Zeng; Lan Zhang; Aaron M Berlin; Lei Chen; Theresa A Hepburn; Justin Johnson; Jamison McCorrison; Jason Miller; Pat Minx; Chad Nusbaum; Carsten Russ; Sean M Sykes; Chad M Tomlinson; Sarah Young; Wesley C Warren; Jonathan Badger; Jonathan Crabtree; Victor M Markowitz; Joshua Orvis; Andrew Cree; Steve Ferriera; Lucinda L Fulton; Robert S Fulton; Marcus Gillis; Lisa D Hemphill; Vandita Joshi; Christie Kovar; Manolito Torralba; Kris A Wetterstrand; Amr Abouellleil; Aye M Wollam; Christian J Buhay; Yan Ding; Shannon Dugan; Michael G FitzGerald; Mike Holder; Jessica Hostetler; Sandra W Clifton; Emma Allen-Vercoe; Ashlee M Earl; Candace N Farmer; Konstantinos Liolios; Michael G Surette; Qiang Xu; Craig Pohl; Katarzyna Wilczek-Boney; Dianhui Zhu Journal: Science Date: 2010-05-21 Impact factor: 47.728
Authors: Matam Vijay-Kumar; Jesse D Aitken; Frederic A Carvalho; Tyler C Cullender; Simon Mwangi; Shanthi Srinivasan; Shanthi V Sitaraman; Rob Knight; Ruth E Ley; Andrew T Gewirtz Journal: Science Date: 2010-03-04 Impact factor: 47.728
Authors: Sergey R Konstantinov; Hauke Smidt; Willem M de Vos; Sven C M Bruijns; Satwinder Kaur Singh; Florence Valence; Daniel Molle; Sylvie Lortal; Eric Altermann; Todd R Klaenhammer; Yvette van Kooyk Journal: Proc Natl Acad Sci U S A Date: 2008-12-01 Impact factor: 11.205
Authors: Gitte S Jensen; Steve G Carter; Stuart G Reeves; Larry E Robinson; Kathleen F Benson Journal: J Med Food Date: 2014-08-08 Impact factor: 2.786